방사선 차폐용 수술용 장갑 시장 : 세계 예측(2026-2032년)

The Radiation Attenuating Surgical Gloves Market is projected to grow by USD 685.48 million at a CAGR of 11.72% by 2032.

Radiation-Attenuating Surgical Gloves: Executive Summary

Radiation-attenuating surgical gloves are protective medical devices designed to reduce hand exposure during procedures involving ionizing radiation, including fluoroscopy-guided interventions and selected imaging-assisted surgeries. Their relevance is shaped by occupational radiation-protection requirements, procedural volume, clinician awareness, dexterity needs, and compatibility with sterile surgical workflows. Product performance must be considered alongside established controls such as time reduction, distance, shielding, dose monitoring, and appropriate operating-room protocols.

Safety Practice Is Shifting Toward Layered Radiation Protection

The landscape is moving from reliance on fixed shielding and individual protective apparel toward layered protection that also considers the hands and other extremities. This shift reflects the growing use of image-guided procedures, greater attention to cumulative occupational exposure, and continued emphasis on the optimization principle of keeping radiation doses as low as reasonably achievable. Adoption depends on whether gloves provide credible attenuation without compromising tactile feedback, fit, sterility, or surgical precision. Clear labeling, validated testing, and education remain important to prevent users from treating attenuating gloves as a substitute for procedural controls.

Artificial Intelligence Can Improve Exposure Control, but Not Replace Protection

Artificial intelligence is increasingly relevant to radiation-enabled care through image optimization, workflow support, dose tracking, procedure planning, and identification of exposure patterns. These capabilities may help clinicians reduce unnecessary imaging time or improve consistency in dose-management decisions. However, AI does not eliminate scattered radiation or the need for personal protective measures. Its practical contribution depends on validated clinical performance, interoperable dose data, transparent decision support, cybersecurity, and human oversight. For glove suppliers and healthcare organizations, the strongest opportunity is to connect product education and usage monitoring with broader digital radiation-safety programs rather than position AI as a standalone substitute for protective equipment.

Regional Insights: Adoption Is Tied to Procedure Mix, Regulation, and Safety Infrastructure

North America generally combines advanced interventional care with mature occupational-safety expectations, making evidence, compliance documentation, and workflow integration important. Europe places strong emphasis on harmonized medical-device requirements and radiation protection, while the European Union's institutional framework encourages standardized quality and traceability practices. Asia-Pacific presents varied conditions: Australia, Japan, South Korea, China, and India differ in healthcare capacity, regulatory implementation, specialist availability, and access to image-guided services. Latin America, including Brazil and Mexico, is influenced by uneven investment, public-private differences, and expanding interventional capabilities. The Middle East, particularly Gulf healthcare systems, often emphasizes advanced hospital infrastructure and international accreditation, whereas Africa remains highly diverse, with adoption shaped by equipment access, training, procurement resources, and radiation-safety capacity.

Group Insights: Economic and Security Alliances Create Different Adoption Contexts

ASEAN markets reflect varied regulatory systems, healthcare investment levels, and access to interventional expertise, so regional harmonization and clinician training can support consistency. BRICS members combine large and diverse healthcare systems with differing procurement priorities and domestic manufacturing capabilities; adoption is likely to depend on affordability, evidence, and local compliance pathways. The European Union benefits from coordinated regulatory principles, although implementation and procurement remain national or institutional matters. G7 settings generally have sophisticated procedural infrastructure and strong attention to occupational safety, with purchasing decisions focused on performance, documentation, and total workflow value. GCC countries often prioritize high-specification hospital environments and internationally aligned standards. NATO members span distinct healthcare systems, but common attention to resilience, clinical readiness, and standardized safety practices can support demand for validated protective solutions.

Country Insights: Local Regulation and Clinical Practice Shape Product Fit

The United States and Canada emphasize occupational exposure management, institutional protocols, and evidence-backed procurement. In Europe, Germany, France, Italy, Spain, and the United Kingdom combine established medical systems with detailed conformity, training, and radiation-protection expectations, although national purchasing processes differ. Australia and Japan place strong importance on clinical quality and disciplined procedural practice, while South Korea combines advanced hospital technology with rigorous product evaluation. China and India offer broad but heterogeneous healthcare environments in which regulatory navigation, local access, training, and cost sensitivity are central considerations. Brazil and Mexico reflect growing interventional capabilities alongside regional variation in resources and procurement. Russia's market context is shaped by domestic regulatory requirements, healthcare infrastructure differences, and the availability of compliant protective products.

Industry Priorities: Prove Protection Without Sacrificing Surgical Performance

Leaders should document attenuation performance using recognized and transparent test methods, clearly state operating limitations, and distinguish hand protection from complete radiation safety. Product development should prioritize dexterity, grip, comfort, sterile compatibility, sizing, and resistance to tearing or puncture. Commercial and clinical teams should work with hospitals to assess procedure-specific exposure, train users on correct application and disposal, and integrate gloves into broader optimization programs. Regional strategies should account for registration pathways, procurement structures, local language requirements, and affordability. Post-market surveillance, user feedback, and independent clinical evaluation can strengthen trust, while digital dose-management partnerships may help demonstrate how protective gloves fit within measurable safety improvements.

Research Methodology: Evidence-Based Review of Product and Adoption Drivers

This executive summary uses the defined market scope of radiation-attenuating surgical gloves and synthesizes evidence-based considerations across occupational radiation protection, image-guided clinical workflows, medical-device quality, regulatory practice, healthcare infrastructure, and technology adoption. The assessment compares the required regions, groups, and countries qualitatively, focusing on documented structural drivers rather than market estimates or projections. It excludes market sizing, shares, forecasts, and unsupported company-specific claims. Interpretations are framed as adoption conditions and strategic implications, with attention to uncertainty caused by differences in national regulation, institutional procurement, procedure mix, and data availability.

Conclusion: Integrated Safety and Clinical Usability Will Define Progress

Radiation-attenuating surgical gloves occupy a specialized role within a broader radiation-protection system. Their value will depend on credible attenuation, dependable quality, clinician usability, and correct integration with shielding, monitoring, equipment optimization, and safe procedural technique. Regional and country differences mean that a single commercialization or education model will not fit every setting. Organizations that combine transparent evidence, practical training, regulatory discipline, and measurable safety objectives will be best positioned to support responsible adoption.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Radiation Attenuating Surgical Gloves Market, by Product Type

• 7.1. Introduction
• 7.2. Composite Gloves
• 7.3. Disposable Gloves
• 7.4. Reusable Gloves
  • 7.4.1. Lead Composite Gloves
  • 7.4.2. Lead Rubber Gloves
  • 7.4.3. Leaded Finger Guards

8. Radiation Attenuating Surgical Gloves Market, by Material

• 8.1. Introduction
• 8.2. Latex
• 8.3. Neoprene
• 8.4. Nitrile

9. Radiation Attenuating Surgical Gloves Market, by Application

• 9.1. Introduction
• 9.2. Cardiology
  • 9.2.1. Electrophysiology
  • 9.2.2. Interventional Cardiology
• 9.3. Interventional Radiology
  • 9.3.1. Neuro Radiology
  • 9.3.2. Vascular Radiology
• 9.4. Oncology
  • 9.4.1. Brachytherapy
  • 9.4.2. External Beam Therapy
• 9.5. Orthopedics
• 9.6. Urology

10. Radiation Attenuating Surgical Gloves Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Diagnostic Centers
  • 10.3.1. Radiology Centers
  • 10.3.2. Specialty Clinics
• 10.4. Hospitals
  • 10.4.1. Government Hospitals
  • 10.4.2. Private Hospitals
• 10.5. Research Institutes

11. Radiation Attenuating Surgical Gloves Market, by Region

• 11.1. Introduction
• 11.2. Asia-Pacific
• 11.3. North America
• 11.4. Latin America
• 11.5. Europe
• 11.6. Middle East
• 11.7. Africa

12. Radiation Attenuating Surgical Gloves Market, by Group

• 12.1. Introduction
• 12.2. ASEAN
• 12.3. GCC
• 12.4. European Union
• 12.5. BRICS
• 12.6. G7
• 12.7. NATO

13. Radiation Attenuating Surgical Gloves Market, by Country

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. United Kingdom
• 13.7. Germany
• 13.8. France
• 13.9. Russia
• 13.10. Italy
• 13.11. Spain
• 13.12. China
• 13.13. India
• 13.14. Japan
• 13.15. Australia
• 13.16. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. Market Concentration Analysis, 2025
  • 14.2.1. Concentration Ratio (CR)
  • 14.2.2. Herfindahl Hirschman Index (HHI)
• 14.3. Recent Developments & Impact Analysis, 2025
• 14.4. Product Portfolio Analysis, 2025
• 14.5. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Ansell Limited
• 15.2. B. Braun Melsungen AG
• 15.3. BarrierSafe Solutions International, Inc.
• 15.4. Bierschneider Medical
• 15.5. Burkhart Roentgen International
• 15.6. Cardinal Health, Inc.
• 15.7. Infab Corporation
• 15.8. Kirwan Surgical Products LLC
• 15.9. MAVIG GmbH
• 15.10. Mercury Medical
• 15.11. Molnlycke Health Care AB
• 15.12. Prima Medical Technologies
• 15.13. R+P GmbH
• 15.14. Sempermed USA, Inc.
• 15.15. TIDI Products, LLC
• 15.16. Univet S.r.l.

16. Key Experts